2-7 循環器内科

診療実績

(人)

(人)

研究・教育活動
英文論文（原著・総説）
1. Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Natsuaki M, Yamaji K, Ogita M, Suwa S,
Isawa T, Domei T, Ando K, Tatsushima S, Watanabe H, Oya M, Kadota K, Tokuyama H, Tada

33

2.

T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Kimura T for the
STOPDAPT-2 ACS Investigators.
Prevalence and effects of high-intensity statins for Japanese patients presenting with acute coronary
syndrome – a post hoc secondary analysis of STOPDAPT-2 ACS-.Circ J. 2022 (Online ahead of print)

3.

Yamaji K, Shiomi H, Morimoto T, Matsumura-Nakano Y, Ehara N, Sakamoto H, Takeji Y,
Yoshikawa Y, Yamamoto K, Kato ET, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T,
Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S,
Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu
N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M,
Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y,
Hanyu M, Domei T, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto
PCI/CABG Registry Investigators.
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization:
CREDO-Kyoto PCI/CABG Registry.
JACC Asia. 2022 Apr 12;2(3):294-308.

4.

Sasahara H, Yatsu S, Wada H, Sai E, Moriya S, Miyazaki S, Kajimoto K, Ogita M, Suwa S.
Multiple Imaging and Surgical Characteristics in Cardiac Metastasis from Undifferentiated Uterine Sarcoma.
Case Rep Cardiol. 2022 Nov 11;2022:6025354.

5.

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic
relationship with cardiovascular events.
Sakuma M, Iimuro S, Shinozaki T, Kimura T, Nakagawa Y, Ozaki Y, Iwata H, Miyauchi K, Daida H, Suwa S,
Sakuma I, Nishihata Y, Saito Y, Ogawa H, Matsuzaki M, Ohashi Y, Taguchi I, Toyoda S, Inoue T, Nagai R.
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship withcardiovascular events.
BMC Med. 2022 Nov 14;20(1):441.

6.

Yamashiro K, Tanaka R, Miyazaki S, Miyauchi K, Hayashi H, Nishizaki Y, Nojiri S, Suwa S,
Sumiyosi M, Nakazato Y, Urabe T, Hattori N, Minamino T, Daida H.
Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation:
Results from the RAFFINE registry.
J Stroke Cerebrovasc Dis. 2022 Dec;31(12):106871.

7.

Takeji Y, Morimoto T, Shiomi H, Kato ET, Imada K, Yoshikawa Y, Matsumura-Nakano Y,
Yamamoto K, Yamaji K, Toyota T, Tada T, Tazaki J, Yamamoto E, Nakatsuma K, Suwa S,
Ehara N, Taniguchi R, Tamura T, Watanabe H, Toyofuku M, Yamamoto T, Shinoda E, Mabuchi
H, Inoko M, Onodera T, Sakamoto H, Inada T, Ando K, Furukawa Y, Sato Y, Kadota K,
Nakagawa Y, Kimura T.
Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention.

34

Circ J. 2022 Nov 8. doi: 10.1253/circj.CJ-22-0517. Online ahead of print.

8.

Yoshikawa Y, Shiomi H, Morimoto T, Takeji Y, Matsumura-Nakano Y, Yamamoto K,
Yamamoto E, Kato ET, Watanabe H, Saito N, Domei T, Tada T, Nawada R, Onodera T, Suwa S,
Tamura T, Ishii K, Ando K, Furukawa Y, Kadota K, Nakagawa Y, Kimura T; CREDO-Kyoto
PCI/CABG Registry Cohort-2 and Cohort-3 Investigators.
Stent-Related Adverse Events as Related to Dual Antiplatelet Therapy in First- vs Second-Generation
Drug-Eluting Stents.
JACC Asia. 2021 Nov 23;1(3):345-356.

9.

Watanabe H, Yamamoto K, Shiomi H, Morimoto T, Kato E, Matsumura Y, Nakatsuma K,
Takeji Y, Yaku H, Yamamoto E, Yamashita Y, Yoshikawa Y, Fuki M, Yamaji K, Ehara N,
Sakamoto H, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T,
Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko
M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A,
Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S,
Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Ando K, Kadota
K, Minatoya K, Nakagawa Y, Kimura T; On behalf the CREDO-Kyoto PCI/CABG Registry
Cohort-3 Investigators.
Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass
grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG
registry Cohort-3.
PLoS One. 2022 Sep 29;17(9):e0267906.

10. Toyota T, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, Inoue T, Nakagawa Y,
Nishihata Y, Daida H, Ozaki Y, Suwa S, Sakuma I, Furukawa Y, Shiomi H, Watanabe H, Yamaji
K, Saito N, Natsuaki M, Ohashi Y, Matsuzaki M, Nagai R, Kimura T.
Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary
Artery Disease - An Observation From the REAL-CAD Study.
Circ J. 2022 Sep 14. doi: 10.1253/circj.CJ-22-0168. Online ahead of print.

11. Sakagami A, Soeda T, Saito Y, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Suwa S,
Fujimoto K, Dai K, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T,
Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K,
Uemura S, Tobaru T, Saku K, Oshima S, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET
investigators.
Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced
ejection fraction after acute myocardial infarction.
J Cardiol. 2023 Jan;81(1):83-90.

35

12. Iso T, Matsue Y, Mizukami A, Tokano T, Isoda K, Suwa S, Miyauchi K, Yanagisawa N,
Okumura Y, Minamino T.
Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled
study.
ESC Heart Fail. 2022 Aug 18. doi: 10.1002/ehf2.14109. Online ahead of print.

13. Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Nishikawa R, Kaneda K, Yamamoto
K, Takeji Y, Komasa A, Yamaji K, Shizuta S, Tada T, Nagao K, Suwa S, Tamura T, Sakamoto H,
Inada T, Matsuda M, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T;
CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators.
Stroke Risk Stratification With the CHADS<sub>2</sub> Score in Patients Without Atrial Fibrillation Who
Underwent Percutaneous Coronary Intervention.
Am J Cardiol. 2022 Oct 15;181:9-17.

14. Natsuaki M, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, Inoue T, Nakagawa Y,
Nishihata Y, Daida H, Ozaki Y, Suwa S, Sakuma I, Furukawa Y, Shiomi H, Watanabe H, Yamaji
K, Saito N, Matsuzaki M, Nagai R, Kimura T; REAL-CAD Investigators.
Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery
Disease - Insights From the REAL-CAD Study.
Circ J. 2022 Aug 25;86(9):1416-1427.

15. Obayashi Y, Watanabe H, Morimoto T, Yamamoto K, Natsuaki M, Domei T, Yamaji K, Suwa S,
Isawa T, Watanabe H, Yoshida R, Sakamoto H, Akao M, Hata Y, Morishima I, Tokuyama H,
Yagi M, Suzuki H, Wakabayashi K, Suematsu N, Inada T, Tamura T, Okayama H, Abe M,
Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y,
Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS Investigators.
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention:
From the STOPDAPT-2 Total Cohort.
Circ Cardiovasc Interv. 2022 Aug;15(8):e012004.

16. Yamamoto MH, Kondo S, Mizukami T, Yasuhara S, Wakabayashi K, Kobayashi N, Sambe T,
Hibi K, Nanasato M, Sugiyama T, Kakuta T, Kondo T, Mitomo S, Nakamura S, Takano M,
Yonetsu T, Ashikaga T, Dohi T, Yamamoto H, Kozuma K, Yamashita J, Yamaguchi J, Ohira H,
Mitsumata K, Namiki A, Kimura S, Honye J, Kotoku N, Higuma T, Natsumeda M, Ikari Y,
Sekimoto T, Mori H, Suzuki H, Otake H, Isomura N, Ochiai M, Suwa S, Shinke T; TACTICS
investigators.
Rationale and design of the TACTICS registry: Optical coherence tomography guided primary percutaneous
coronary intervention for patients with acute coronary syndrome.
J Cardiol. 2022 Dec;80(6):505-510. doi: 10.1016/j.jjcc.2022.07.002. Epub 2022 Jul 2

36

17. Ishihara M, Asakura M, Hibi K, Okada K, Shimizu W, Takano H, Suwa S, Fujii K, Okumura Y,
Mano T, Tsujita K, Igeta M, Okamoto R, Suna S.
Evoocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary
intervention: the randomised, open-label EVOCATION trial.
EuroIntervention. 2022 Oct 7;18(8):e647-e655.
18. Miyazaki S, Miyauchi K, Hayashi H, Yamashiro K, Tanaka R, Nishizaki Y, Nojiri S, Suwa S, Sumiyoshi M,
Nakazato Y, Urabe T, Hattori N, Minamino T, Daida H.
Tre. nds of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the
RAFFINE registry.
J Cardiol. 2022 Jul;80(1):41-48

19. Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T,
Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H,
Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K,
Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2
ACS Investigators.
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Monthsof Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS
Randomized Clinical Trial.
JAMA Cardiol. 2022 Apr 1;7(4):407-417.

20. Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Yamaji K, Matsumura-Nakano Y,
Yoshikawa Y, Yamamoto E, Fuki M, Kato E, Yamashita Y, Yaku H, Nakatsuma K, Watanabe H,
Matsuda M, Tamura T, Inoko M, Mabuchi H, Shirotani M, Eizawa H, Ishii K, Inada T, Onodera
T, Shinoda E, Yamamoto T, Toyofuku M, Takahashi M, Sakamoto H, Miki S, Aoyama T, Suwa
S, Sato Y, Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; Credo-Kyoto PCI/CABG
Registry Investigators.
Coronary Artery Disease Without Standard Cardiovascular Risk Factors.
Am J Cardiol. 2022 Feb 1;164:34-43.

21. Differences in mortality and causes of death between STEMI and NSTEMI in the early and latephases after acute myocardial infarction.
Takeji Y, Shiomi H, Morimoto T, Yamamoto K, Matsumura-Nakano Y, Nagao K, Taniguchi R, Yamaji K,
Tada T, Kato ET, Yoshikawa Y, Obayashi Y, Suwa S, Inoko M, Ehara N, Tamura T, Onodera T, Watanabe H,
Toyofuku M, Nakatsuma K, Sakamoto H, Ando K, Furukawa Y, Sato Y, Nakagawa Y, Kadota K, Kimura T;
CREDO-Kyoto AMI Registry Wave-2 Investigators.
Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after
acute myocardial infarction.
PLoS One. 2021 Nov 17;16(11):e0259268.

3722. Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, Takeji Y, Tada T, Nagao
K, Yamaji K, Kaneda K, Suwa S, Tamura T, Sakamoto H, Inada T, Matsuda M, Sato Y,
Furukawa Y, Ando K, Kadota K, Nakagawa Y, Kimura T; CREDO‐Kyoto AMI RegistryWave‐2 Investigators.
Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction.
J Am Heart Assoc. 2021 Sep 21;10(18):e021417.

23. Natsuaki M, Morimoto T, Shiomi H, Yamamoto K, Yamaji K, Watanabe H, Uegaito T, Matsuda
M, Tamura T, Taniguchi R, Inoko M, Mabuchi H, Takeda T, Domei T, Shirotani M, Ehara N,
Eizawa H, Ishii K, Tanaka M, Inada T, Onodera T, Nawada R, Shinoda E, Yamada M,
Yamamoto T, Sakai H, Toyofuku M, Tamura T, Takahashi M, Tada T, Sakamoto H, Tada T,
Kaneda K, Miki S, Aoyama T, Suwa S, Sato Y, Ando K, Furukawa Y, Nakagawa Y, Kadota K,
Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-Investigators.
Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan- From the

CREDO-Kyoto Registry Cohort-2 and Cohort-3.
Circ J. 2022 Apr 25;86(5):748-759.

24. Asakura M, Hibi K, Shimizu W, Fujii K, Suwa S, Okumura Y, Mano T, Igeta M, Okamoto R,
Ishihara M.
Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing theeffect of evolocumab on coronary microvascular function after percutaneous coronary intervention inpatients with stable coronary artery disease.
J Cardiol. 2022 Jan;79(1):105-109.

25. Goto C, Yatsu S, Wada H, Suwa S.
Venous thrombosis via pulmonary arteriovenous malformation causing acute myocardial infarction in a
relatively young female patient.
BMJ Case Rep. 2022 Feb 28;15(2):e247846.

26. Moriya S, Wada H, Iwata H, Endo H, Doi S, Ogita M, Dohi T, Okazaki S, Suwa S, Miyauchi K,
Daida H, Minamino T.
Red Cell Distribution Width Predicts Long-Term Cardiovascular Outcomes in Patients with Chronic
Coronary Syndrome.
Int Heart J. 2022;63(6):1041-1047.

27. Nishiyama H, Funamizu T, Iwata H, Endo H, Chikata Y, Doi S, Wada H, Naito R, Ogita M,
Kato Y, Okai I, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T.
Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following
percutaneous coronary intervention: A 10-year follow-up study.
Int J Cancer. 2022 Nov;151(9):1482-1490

38

28. Sonoda T, Wada H, Ogita M, Takahashi D, Nishio R, Yasuda K, Takeuchi M, Yatsu S, Shitara J,
Tsuboi S, Dohi T, Suwa S, Miyauchi K, Minamino T.
Clinical features and predictors of outcome in patients with acute myocardial infarction complicated byout-of-hospital cardiac arrest.
BMC Cardiovasc Disord. 2022 Apr 19;22(1):185..

29. Ando H, Yamaji K, Kohsaka S, Ishii H, Wada H, Yamada S, Sawano M, Inohara T, Numasawa
Y, Ikari Y, Amano T; J-PCI Registry Investigators.
Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospitaloutcomes.
Cardiovasc Interv Ther. 2022 Apr;37(2):243-247.

30. Takahashi D, Wada H, Ogita M, Yasuda K, Nishio R, Takeuchi M, Shitara J, Tsuboi S, Dohi T,
Suwa S, Miyauchi K, Daida H, Minamino T.
Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With
Acute Coronary Syndrome Treated With Statins.
Am J Cardiol. 2022 Apr 1;168:11-16.

31. Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, Wada H, Ishii H, Amano T, Miyata H,
Ikari Y; J-PCI Registry Investigators.
Percutaneous coronary intervention during the COVID-19 pandemic in Japan: Insights from the nationwide
registration data.
Lancet Reg Health West Pac. 2022 Mar;22:100434

32. Chikata Y, Iwata H, Miyosawa K, Koike T, Yasuda H, Funamizu T, Doi S, Endo H, Wada H,
Naito R, Ogita M, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T.
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after
percutaneous coronary intervention via insulin-like growth factor-1 axis. Sci Rep. 2022 Mar;12(1):5129

33. Ito T, Yamaji K, Kohsaka S, Ishii H, Wada H, Amano T, Fujita H, Seo Y, Ikari Y.
Effect of Procedural Volume on In-Hospital Outcomes After Percutaneous Coronary Intervention in Patients
With Chronic Kidney Disease (from the Japanese National Clinical Data [J-PCI Registry]).
Am J Cardiol. 2022 Feb;165:12-18.

34. Funamizu T, Iwata H, Chikata Y, Doi S, Endo H, Wada H, Naito R, Ogita M, Kato Y, Okai I,
Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T.
A Prognostic Merit of Statins in Patients with Chronic Hemodialysis after Percutaneous Coronary
Intervention-A 10-Year Follow-Up Study.
J Clin Med. 2022 Jan;11(2):390

39

35. Ueki Y, Kuramitsu S*, Saigusa T, Senda K, Matsuo H, Horie K, Takashima H, Terai H, Kikuta
Y, Ishihara T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T,
Sasaki Y, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Kanemura N, Sonoda S, Yokoi
H, Tanaka N; J-CONFIRM Investigators.
Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided
by Fractional Flow Reserve.
Circ J. 2022 Mar 12. doi: 10.1253/circj.CJ-21-1024.
36. Shiono Y, Kuramitsu S*, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T,
Saigusa T, Sakamoto T, Suematsu N, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota
F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Tanaka A, Yokoi H, Tanaka
N; J-CONFIRM Registry Investigators.
Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After
Fractional Flow Reserve Assessment.
JACC Cardiovasc Interv. 2022 Feb 28;15(4):427-439.

37. Kuramitsu S*, Matsuo H, Shinozaki T, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T,
Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T,
Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Yokoi H, Tanaka N;
J-CONFIRM Investigators.
Five-Year Outcomes After Fractional Flow Reserve-Based Deferral of Revascularization in
Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry.
Circ Cardiovasc Interv. 2022 Feb;15(2):e011387.
38. Ishii M, Kuramitsu S*, Yamanaga K, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y,
Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Masamura K, Doijiri T,
Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Kanemura N, Sonoda S, Yokoi
H, Tanaka N, Tsujita K; J- CONFIRM Registry Investigators.
Association of Guideline-Directed Medical Therapy Adherence with Outcomes After Fractional
Flow Reserve-Based Deferral of Revascularization.
Eur Heart J Cardiovasc Pharmacother. 2022 Feb 2 (Online ahead of print).

和文著書
守屋 壮志、藤田 航、中村 優、真 優スレーシュワル、石川 剛、安田 健太郎、園田 健人、設樂 準、
髙野 信太郎、和田 英樹、塩澤 知之、荻田 学、諏訪 哲. 当院における 12 誘導心電図伝送システ
ムに対するこれまでの取組み.ICU と CCU vol.46 2022 年 8 月

40

国際学会（発表）
1. Wada H, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M,
Hagiwara N, Hirayama A, Matsui K, Ofawa H.
Antithrombotic and proton pump inhibitor co-therapy in patients with atrial fibrillation and stable coronary
disease: a post hoc analysis of the AFIRE trial
ESC2022, 2022/8/26-8/29

2.

Singh YS, Wada H, Ogita M, Nakamura Y, Moriya S, Ishikawa G, Yasuda K, Shitara J, Suwa S,
Miyauchi K, Minamino T.
Standard modifiable cardiovascular risk factors and long-term clinical outcomes among patients with
ST-elevation myocardial infarction.
AHA2022, 2022/11/05-11/07

3.

Wada H, Miyauchi K, Suwa S, Miyazaki S, Hayashi H, Sumiyoshi M, Nakazato Y, Minamino
M, Daida H.
Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The
RAFFINE registry subanalysis.
AHA2022, 2022/11/05-11/07

国内学会（招聘講演）
1. 塩澤 知之 ICD・CRT の適応と最近の特殊機能に関して.
第 46 回 CVIT 東海北陸地方会、2022/5/27-28(Web 開催)
2. 荻田 学 冠動脈疾患における抗血栓薬のマネージメント～最近の知見を踏まえて～.
第 46 回 CVIT 東海北陸地方会、2022/5/27-28(Web 開催)
国内学会（発表）
1. Hideki Wada, Katsumi Miyauchi, Satoru Suwa, Sakiko Miyazaki, Hidenori Hayashi, Ryota
Tanaka, Shuko Nojiri, Miyazaki Tadashi, Masataka Sumiyoshi, Yuji Nakazato, Takao Urabe,
Nobutaka Hattori, Tohru Minamino, Hiroyuki Daida. Impact of Atrial Fibrillation Type
(Paroxysmal vs. Non-paroxysmal) on Long-term Clinical Outcomes: The RAFFINE Registry
Subanalysis. 第 86 回日本循環器学会、2022/3/11-3/13(Web 開催)
2. 中村 優 膝窩動脈瘤内の血栓により閉塞を来した急性下肢虚血の 1 例.
第 46 回 CVIT 東海北陸地方会、2022/5/27-28(Web 開催)
3. 小田 遼馬、大石 淳実、上川 祐輝、中村 優、設樂 準、髙野 信太郎、和田 英樹、塩澤 知之、荻田 学、諏訪 哲、梶本 完．亜急性心筋梗塞加療中に突如出現した左室内
巨大血栓に対して内視鏡下血栓除去術を施行した 1 例．第 159 回日本循環器学会東海41

地方会、2022/6/4

4. 石川剛、和田英樹、藤田航、中村優、真優スレーシュワル、設楽準、高野信太郎、塩澤知之、荻田学、諏訪哲. うっ血性心不全が疑われ加療を行うも卵巣腫瘍摘出後に改善した Meigs 症候群の一例. 日本内科学会第 247 回東海地方会 2022/6/26(Web 開催)
5. 和田英樹、宮内克己ら. （口演） 心房細動を合併した安定冠動脈疾患患者における抗凝固薬とプロトンポンプ阻害薬併用の有用性について;AFIRE 研究サブ解析 第 70 回日
本心臓病学会学術集会 2022/9/24
6. 藤田 航、和田 英樹、阿部 圭希、真 優スレーシュワル、中村 優、設樂 準、髙野 信
太郎、塩澤 知之、荻田 学、諏訪 哲、梶本 完. 可動性弓部大動脈内血栓症の 1 例.
日本循環器学会 第 160 回東海・第 145 回北陸合同地方会、2022/10/15-16
7. 設樂準. オレキシン受容体拮抗薬が不眠症を有する心不全患者の睡眠呼吸障害と血行動態に与える影響に関する検討 第 26 回日本心不全学会学術集会 2022/10/22-10/23
研究費（公的資金）
1. 和田英樹 研究代表者 急性心筋梗塞二次予防における遠隔医療の有用性の解明
本学術振興会 若手研究 2022 年～2024 年

日

研究費（治験）モニタリング・監査・審査料・手数料等・製造販売後調査を含む

１． 日本新薬(株)査)
２． 興和㈱ウプトラビ錠 0.2mg・0.4mg

パルモディア錠 0.1mg

３． ヤンセンファーマ㈱特定使用成績調査(長期使用に関する調

長期使用に関する特定使用成績調査

オプスミット錠 10mg 特定使用成績調査（長期使用）

４． 小野薬品工業㈱ オノアクト®一般使用成績調査〔生命に危険のある下記の不整脈で難治性かつ緊急を要する場合：心室細動、血行動態不安定な心室頻拍〕
５． ㈱生命科学インスティテュート ST 上昇型急性心筋梗塞患者を対象とした CL2020 の検証的試験
６． CRL ベーリング㈱ 急性冠症候群患者を対象とした CSL112 の有効性及び安全性を検討する多施設共同二重盲検無作為化プラセボ対照並行群間比較第 3 相臨床試験
７． ラボコープ・ディベロップメント・ジャパン㈱ EMPACT-MI：急性心筋梗塞患者の心不全による入院及び死亡に対するエンパグリフロジンの効果を評価する効率化、多施
設共同、ランダム化、並行群間、二重盲検、プラセボ対照、優越性

42

８． ノバルティス ファーマ㈱ 心血管疾患の既往を有する患者を対象として， TQJ230のリポ蛋白(a)低下作用が主要な心血管系イベント に対してもたらす影響を評価す
る，ランダム化，二重盲検， プラセボ対照，多施設共同試験

研究費（受託・共同研究）
1. 兵庫医科大学病院 経皮的冠動脈形成術施行患者におけるエボロクマブの周術期微小循環障害に対する軽減効果を検討する【EVOCATION】
2. 一般財団法人 生産開発科学研究所 エベロリムス溶出性コバルトクロムステント留置後の抗血小板療法を P2Y12 阻害薬単剤とすることの安全性を評価する研究【STOPDAPT】
3. 一般財団法人 生産開発科学研究所 実地臨床におけるバイオリムス溶出性ステントとエベロリムス溶出性ステントの有効性および安全性についての多施設前向き無作為化オープンラベル比較試験：長期追跡試験【NEXT Trial: Extended Follow-up Study】
4. 一般財団法人 生産開発科学研究所 慢性冠動脈疾患患者におけるイコサペント酸エチルの二次予防効果の検討【RESPECT-EPA】
5. 一般財団法人 生産開発科学研究所 至適な血管内超音波ガイド経皮的冠動脈インターベンションの複雑性病変における臨床経過を評価する前向き観察研究【OPTIVUS】
6. シー・ブイ・クエスト㈱ 複雑病変を有する冠動脈をゾタロリムス溶出ステントで治療した症例の複数施設による登録研究【ARCADIA ZERO】
7. 昭和大学医学部内科講座循環器内科学部門 光干渉断層映像法による急性冠症候群の発症メカニズムの解明と予後に関する研究【TACTICS】
8. 昭和大学医学部内科講座循環器内科学部門 光干渉断層映像法ガイド下血行再建術の患者背景に関する研究【TACTICS background registry】

43